Please wait a minute...
J Zhejiang Univ (Med Sci)  2019, Vol. 48 Issue (4): 367-372    DOI: 10.3785/j.issn.1008-9292.2019.08.03
    
Genetic analysis and prenatal diagnosis of a sporadic family with neurofibromatosis type 1
LIU Bei(),YANG Yanmei,YAN Kai,CHEN Min,WANG Liya,HUANG Yingzhi,QIAN Yeqing,DONG Minyue*()
Key Laboratory of Reproductive Genetics, Ministry of Education, Department of Reproductive Genetics, Women's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China
Download: HTML( 14 )   PDF(1079KB)
Export: BibTeX | EndNote (RIS)      

Abstract  

Objective: To identify pathogenic mutation for a family with neurofibromatosis type 1(NF1) and provide prenatal diagnosis for them. Methods: Mutation analysis of the sporadic family with NF1 was performed with target captured next generation sequencing and Sanger sequencing. RNA samples were extracted from the lymphocytes of NF1 patient and her parents. RT-PCR and Sanger sequencing were performed to analyze the relative mRNA expression in the samples. Prenatal diagnosis of the pathogenic mutation was offered to the fetus. Results: A novel splicing mutation c.1260+4A>T in the NF1 gene was found in the proband of the family, but was not found in her parents.cDNA sequencing showed that 13 bases inserted into the 3' end of exon 11 in the NF1 gene lead to a frameshift mutation. Prenatal diagnosis suggested that the fetus did not carried the mutant. Conclusion: The NF1: c.1260+4A>T mutation found in the NF1 patient is considered to be pathogenic, which provides information for family genetic counseling and prenatal diagnosis.



Key wordsNeurofibroma/genetics      Genes, neurofibromatosis 1      Amniotic fluid      Prenatal diagnosis      Genetic testing      Pedigree      Mutation      Exons      Polymerase chain reaction     
Received: 28 March 2019      Published: 30 October 2019
CLC:  R394.3  
Corresponding Authors: DONG Minyue     E-mail: liubei@zju.edu.cn;dongmy@zju.edu.cn
Cite this article:

LIU Bei,YANG Yanmei,YAN Kai,CHEN Min,WANG Liya,HUANG Yingzhi,QIAN Yeqing,DONG Minyue. Genetic analysis and prenatal diagnosis of a sporadic family with neurofibromatosis type 1. J Zhejiang Univ (Med Sci), 2019, 48(4): 367-372.

URL:

http://www.zjujournals.com/med/10.3785/j.issn.1008-9292.2019.08.03     OR     http://www.zjujournals.com/med/Y2019/V48/I4/367


Ⅰ型神经纤维瘤一家系的基因检测及产前诊断

目的: 对一个Ⅰ型神经纤维瘤家系进行遗传学病因分析及产前诊断。方法: 应用目标捕获高通量测序和Sanger测序技术,对一个散发的Ⅰ型神经纤维瘤家系进行基因突变分析。提取先证者及其父母外周血淋巴细胞RNA,行RT-PCR及扩增产物测序分析。明确突变致病性后,抽取羊水标本对胎儿行产前基因诊断。结果: 先证者NF1基因存在c.1260+4A>T杂合剪接突变,为新发突变。RNA剪接分析提示先证者NF1基因发生转录时,11号外显子3'端发生相邻内含子区13个碱基的插入,理论上可导致蛋白编码提前终止,产生截短蛋白,影响蛋白功能。产前基因检测结果显示胎儿未携带该突变。结论: NF1:c.1260+4A>T杂合剪接突变是该Ⅰ型神经纤维瘤患者的致病原因,本研究结果为该家系遗传咨询和产前诊断提供了理论依据。


关键词: 神经纤维瘤/遗传学,  基因, 神经纤维瘤病1型,  羊水,  产前诊断,  基因检测,  系谱,  突变,  外显子,  聚合酶链反应 
Fig 1 Sequencing results of NF1 gene
Fig 2 Sequencing results of cDNA and splice analysis
[1]   XU W , YANG X , HU X et al. Fifty-four novel mutations in the NF1 gene and integrated analyses of the mutations that modulate splicing[J]. Int J Mol Med, 2014, 34 (1): 53- 60
doi: 10.3892/ijmm.2014.1756
[2]   KEHRER-SAWATZKI H , MAUTNER V F , COOPERD N . Emerging genotype-phenotype relation-ships in patients with large NF1 deletions[J]. Hum Genet, 2017, 136 (4): 349- 376
doi: 10.1007/s00439-017-1766-y
[3]   HINMAN M N , SHARMA A , LUO G et al. Neurofibromatosis type 1 alternative splicing is a key regulator of Ras signaling in neurons[J]. Mol Cell Biol, 2014, 34 (12): 2188- 2197
doi: 10.1128/MCB.00019-14
[4]   CUI Y , MORRISON H . Construction of cloning-friendly minigenes for mammalian expression of full-length human NF1 isoforms[J]. Hum Mutat, 2019, 40 (2): 187- 192
doi: 10.1002/humu.23681
[5]   PELTONEN S , KALLIONP?? R A , PELTONEN J . Neurofibromatosis type 1(NF1) gene:Beyond café au lait spots and dermal neurofibromas[J]. Exp Dermatol, 2017, 26 (7): 645- 648
doi: 10.1111/exd.13212
[6]   BANERJEE S , LEI D , LIANG S et al. Novel phenotypes of NF1 patients from unrelated Chinese families with tibial pseudarthrosis and anemia[J]. Oncotarget, 2017, 8 (24): 39695- 39702
[7]   GUTMANN D H , FERNER R E , LISTERNICKR H et al. Neurofibromatosis type 1[J]. Nat Rev Dis Primers, 2017, 3:17004
doi: 10.1038/nrdp.2017.4
[8]   LISTED N A . Nationalinstitutes of health consensus development conference statement on neurofibromatosis[J]. Arch Neurol, 1988, 45:575- 578
doi: 10.1001/archneur.1988.00520290115023
[9]   RICHARDS S , AZIZ N , BALE S et al. Standards and guidelines for the interpretation of sequence variants:a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17 (5): 405- 424
doi: 10.1038/gim.2015.30
[10]   JETT K , FRIEDMAN J M . Clinical and genetic aspects of neurofibromatosis 1[J]. Genet Med, 2010, 12 (1): 1- 11
doi: 10.1097/GIM.0b013e3181bf15e3
[11]   TSIPI M , POULOU M , FYLAKTOU I et al. Phenotypic expression of a spectrum of neurofibromatosis type 1(NF1) mutations identified through NGS and MLPA[J]. J Neurol Sci, 2018, 395:95- 105
doi: 10.1016/j.jns.2018.10.006
[12]   PALMA MILLA C , LEZANA ROSALES J M , LóPEZ MONTIEL J et al. Neurofibromatosis type Ⅰ:mutation spectrum of NF1 in spanish patients[J]. Ann Hum Genet, 2018, 82 (6): 425- 436
doi: 10.1111/ahg.12272
[13]   KOCZKOWSKA M , CHEN Y , CALLENS T et al. Genotype-phenotype correlation in NF1:evidence for a more severe phenotype associated with missense mutations affecting NF1 codons 844-848[J]. Am J Hum Genet, 2018, 102 (1): 69- 87
[14]   UPADHYAYA M , KLUWE L , SPURLOCK G et al. Germline and somatic NF1 gene mutation spectrum in NF1-associated malignant peripheral nerve sheath tumors (MPNSTs)[J]. Hum Mutat, 2008, 29 (1): 74- 82
[15]   PROS E , GóMEZ C , MARTíN T et al. Nature and mRNA effect of 282 different NF1 point mutations:focus on splicing alterations[J]. Hum Mutat, 2008, 29 (9): E173- E193
doi: 10.1002/humu.20826
[1] ZHANG Dandan,WANG Junmei. Prenatal diagnosis and management of fetal hepatic hemangioma[J]. J Zhejiang Univ (Med Sci), 2019, 48(4): 439-445.
[2] YE Qing,ZHANG Yingying,WANG Jingjing,MAO Jianhua. Analysis of Alport syndrome induced by type IV collagen alpha 5 gene mutation in two families[J]. J Zhejiang Univ (Med Sci), 2019, 48(4): 384-389.
[3] XU Yuqing,QIAN Yeqing,YAO Weimiao,DONG Minyue. Genetic analysis of a family of Van der Woude syndrome[J]. J Zhejiang Univ (Med Sci), 2019, 48(4): 378-383.
[4] LOU Tie,HUANG Yingzhi,DONG Minyue. Genetic study of a family of neuronal ceroid lipofuscinosis caused by a heterozygous mutation of CLN6 gene[J]. J Zhejiang Univ (Med Sci), 2019, 48(4): 373-377.
[5] YIN Yixuan,ZHU Hui,QIAN Yeqing,JIN Jinglei,MEI Jin,DONG Minyue. Noninvasive prenatal screening for twin pregnancy: an analysis of 2057 cases[J]. J Zhejiang Univ (Med Sci), 2019, 48(4): 403-408.
[6] LEI Yu,DONG Minyue. Association of maternal age with fetal sex chromosome aneuploidies[J]. J Zhejiang Univ (Med Sci), 2019, 48(4): 409-413.
[7] LUO Yuqin,SHEN Min,SUN Yixi,QIAN Yeqing,WANG Liya,YU Jialing,HU Junjie,JIN Fan,DONG Minyue. Genetic analysis of a fetus with multiple malformations caused by complex translocations of four chromosomes[J]. J Zhejiang Univ (Med Sci), 2019, 48(4): 397-402.
[8] MEI Jin,LIU Jiao,WANG Min,ZHANG Wen,WANG Hao,LU Sha,HE Chaying,JIN Chunlei. Prenatal diagnosis and pregnancy outcomes of 22q11.2 duplication syndrome: analysis of 8 cases[J]. J Zhejiang Univ (Med Sci), 2019, 48(4): 429-433.
[9] HONG Pingping,GUO Bingjie,LIN Li,LIN Xihua,ZHOU Jiaqiang. A novel mutation W257R in GCK gene discovered from a Chinese patient with maturity onset diabetes of the young[J]. J Zhejiang Univ (Med Sci), 2019, 48(2): 200-203.
[10] DU Dongfen,ZHU Lixia,WANG Yungui,YE XiujinG. Expression of WT1 gene and its prognostic value in patients with acute myeloid leukemia[J]. J Zhejiang Univ (Med Sci), 2019, 48(1): 50-57.
[11] TANG Siyang,YE Jia,LI Yuezhou. I1363T mutation induces the defects in fast inactivation of human skeletal muscle voltage-gated sodium channel[J]. J Zhejiang Univ (Med Sci), 2019, 48(1): 12-18.
[12] YIN Li,LI Ge,SHEN Jian,LIU Zhenjie. Screening for inherited thrombophilia and genome sequencing[J]. J Zhejiang Univ (Med Sci), 2018, 47(6): 606-611.
[13] SHI Ting,YE Xiujin. Roles of CCAAT enhancer binding protein α in acute myeloblastic leukemia[J]. J Zhejiang Univ (Med Sci), 2018, 47(5): 552-557.
[14] WENG Binghuan,XU Wei,SU Lan,SHEN Min,LI Rong,XU Xiaopeng,LI Lanjuan. Establishment of cell lines for quality control of prenatal genetic diagnosis by SV40LT gene transfection[J]. J Zhejiang Univ (Med Sci), 2018, 47(5): 520-524.
[15] WANG Jiajing,GU Haiying. Research progress on genotyping of Helicobacter pylori[J]. J Zhejiang Univ (Med Sci), 2018, 47(1): 97-103.